Leukamia and Transfusion Medicine
Leukamia and Transfusion Medicine
Leukamia and Transfusion Medicine
medicine
leukamia
• Blood cancer
• Acute lymphoid leukamia-T and B cell
• Acute myeloid leukamia
• Chronic lymphoid leukamia
• Chronic myeloid leukamia
Acute leukamia
• Clonal proliferation of hematopoietic stem cells
with decreased ability to differentiate into
mature elements presents with blasts in bone
marrow and periphery consequently low RBCs,
platelets, and neutrophils
• Risk factors are radiation, chemo (alkylating
agents, topo II inhib), benzene, smoking and
inherited like down syndrome,klinefelters,fanconi
• AML-peak at >65 and also 20-30
• ALL-peak at 10 years.another pick in elderly
Acute myeloid leukamia
• Peak age of 67 years
• Risk factors
– Heredity-down syndrome,hereditary
telangiectasia
– radiation
– chemical and other occupational exposures,
– and drugs e alkylating agents
• Classification is by WHO and FAB
CLINICAL PRESENTATION
• Less than 3months history due to
anemia,leucocytosis/leucopnea/leucocyte
abnormalities,thrombocytopenea
• Fatigue/weakness
• Anorexia and weight loss
• Easy bruisability/bleeding
• Fever
• Bone pain
• Lymphadenopathy
• Splenomegally
• Myeloid sarcoma-tumor mass eg on skin,lymphnode,
laboratory
• Full hemogram
– Leucocytosis,normal or leucopenea
– Normocytic-normochromic anemia commonest
– Low reticulocyte count
– Thrombocytopenea
• PBF-Auer rods(abnormal shaped rods in the cytoplasm of
the blast cells)
• Bone marrow aspirate/trephine biopsy shows a
hypercellular marrow with blasts
• Flow cytometry
• immunophenotyping
• Others-inceased uric acid,LDH,
Management principles
• Supportive management-
– optimize hemoglobin,platelets,hydration and
– manage tumor lysis syndrome- hyperuricemea/kalemea,hypoCa2+
– Proper hydration
– Treat infections –neutropenic fever
– Pneumocystitis jirovecii prophylaxis
– Psychologic support
• Definitive management
– Induction of remission-destroys bulk of the tumor through
combination chemotherapy
– Remission consolidation-after remission achieved
– Remission maintenance-after consolidation achieved
– Intrathecal chemotherapy and radiotherapy for CNS disease in ALL
• Bone marrow transplantion
Chronic myeloid leukamia
• a clonal expansion of a hematopoietic stem
cell possessing a reciprocal translocation
between chromosomes 9 and 22. the BCR-
ABL1 gene/philadelphia chromosome which
codes for cytokine kinase and oncogene
• All haematopoetic lines affected but
granulocyte affected more
• Occurs in old age peak age 55
• Has three phases
– Chronic phase-disease responsive to drugs.
– Accelerated phase-disease control more difficult
– Blast crises-disease transforms into acute
leukamia.70% AML,30% ALL
• Symptoms
– Fatigue,weight loss,lethargy,anorexia,sweating
– Abdominal pain from splenomegally
– Breathlesness,bruising
– Massive splenomegally
• Investigation
– Hemogram-leucocytosis of upto 300,000/ml with high
platelets count,normocytic anemia
– PBF-whole spectrum of neutrophils form immature to
mature.myeloblasts <10%
– Bone marrow-phase and confirm diagnosis
– Chromosome analysis
– PCR for BCR-ABL gene
• Treatment-tyrosine kinase inhibitors eg imatinib
Chronic lymphocytic leukamia
• 30% of all leukamias
• Peak age 65-70 years
• Insidious disease,diagnosis incidental
• Anemia,infections,painless
lymphadenpathy,weight loss,splenomegally
• Diagnosis-PBF showing lymphocytosis >5k
then immunophenotyping for B cell surface
antigens eg CD 19,20
lymphoma
• Maligancy of lymphoid tissue
• Hodgkins or non hodgkins
• Majority are B cell in origin
• Clinical features
– Progressive painless lymphadenopathy
– Constitutional B signs of weight loss,fever,night
sweat
– hepatosplenomegally
Investigations